TENCENT ANNOUNCES 2024 ANNUAL AND FOURTH QUARTER RESULTS

Achieved High Quality Revenue Growth with Sustained Operating Leverage More Than Doubled Share Repurchaseto Approximately HKD112bn

Top Month

Mar 20, 2025

Jacobio Pharma Announces 2024 Annual Results

BEIJING,SHANGHAI and BOSTON,March 19,2025-- Jacobio Pharma (1167.HK) released its 2024 annual results,with revenue of RMB160million,R&D expense of RMB330 million. Major operating and financing act

Top Month

Mar 20, 2025

Top 10 Growth Opportunities in the Chemicals Sector, 2025

Stricter Regulations,Sustainability Demands,and Digital Innovation to Spur Global Chemicals Industry Transformation

Top Month

Mar 20, 2025

Henlius Receives Orphan Drug Designation for Innovative Anti-HER2 mAb HLX22 in the U.S. for Gastric Cancer

SHANGHAI,March 19,2025-- Shanghai Henlius Biotech,Inc. (2696.HK) announced that the U.S.Food and Drug Administration(FDA) has granted Orphan Drug Designation (ODD) for HLX22,the company\'s innovativea

Top Month

Mar 20, 2025

HiRO and Hallym University Sacred Heart Hospital Sign Strategic MOU to Advance Drug Development

SEOUL,South Korea,March 20,2025-- Harvest Integrated Research Organization (HiRO),a boutique global CRO,is pleased to announce the signing of a Memorandum of Understanding (MOU) with Hallym Universit

Top Month

Mar 20, 2025

Asia-Pacific Road User Charging Alliance Established to Drive Regional Collaboration

TAIPEI,March 20,2025-- A major step toward advancing road user charging (RUC) and intelligent transportation systems (ITS) in the Asia-Pacific region has been achieved with the formation of the Asia-

Top Month

Mar 20, 2025